Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum (II) in rats

M. Esposito, M. Vannozzi, M. Viale, C. Pellecchia, D. Civalleri, L. Gogioso

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Para-aminobenzoic acid (PABA) has been previously repelled as being an inhibitor of DDP toxicity, and its use did not result in any observable loss in antitumor activity of DDP. The following studies investigated the effect of PABA on the pharmocokinetics and urinary excretion of cis-diammine-dichloroplatinum(II) (DDP) in male Sprague-Dawley rats. DDP was injected i.p. at the dose of 7.5 mg/kg in normal saline alone and with a concurrent i.p. injection of PABA (100 mg/kg). The combined treatment with PABA produced a significant increase in the plasma concentrations of total platinum, without affecting the levels of platinum species in the plasma ultrafiltrate. Similar results were also obtained in additional studies in rats receiving the same dose of DDP plus PABA through different routes of administration tie. DDP i.v. and PABA i.p.). Both the area under the total platinum plasma concentration-time curve (AUC) up to 60 min and AUC0-120 min were increased by PABA by an average of 113% and 66%, respectively. The administration of PABA in rats was followed by a substantial reduction in total urinary excretion of platinum (P <0.05) and by a significant (P <0.01) lower concentration of DDP derived platinum in the urine collected during the first 4 h after treatment. The renal clearance of filterable platinum was reduced by PABA by an average of 67.5% from 1.11 to 0.36 ml/min/100 g body wt. Total 24-h urinary excretion of platinum was also decreased, although not significantly, by PABA. Urine volumes from rats treated with DDP + PABA were similar to those from animals receiving DDP alone. HPLC studies indicate that PABA reacts readily with the species generated from DDP in vitro, while the agent is essentially unreactive toward the parent DDP and does nor influence its decomposition rate. The overall data of this study suggest that the protective effect exerted by PABA on DDP toxicity may be at least partially due to its ability to interact with aquated DDP as well as to alter the renal excretion of platinum.

Original languageEnglish
Pages (from-to)2541-2547
Number of pages7
JournalAnticancer Research
Volume15
Issue number6 B
Publication statusPublished - 1995

Fingerprint

4-Aminobenzoic Acid
Cisplatin
Pharmacokinetics
Platinum
Urine
Area Under Curve
Sprague Dawley Rats

Keywords

  • Acid
  • cis-diamminedichloroplatinum(II)
  • Para-aminobenzoic
  • Pharmacokinetic interaction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Esposito, M., Vannozzi, M., Viale, M., Pellecchia, C., Civalleri, D., & Gogioso, L. (1995). Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum (II) in rats. Anticancer Research, 15(6 B), 2541-2547.

Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum (II) in rats. / Esposito, M.; Vannozzi, M.; Viale, M.; Pellecchia, C.; Civalleri, D.; Gogioso, L.

In: Anticancer Research, Vol. 15, No. 6 B, 1995, p. 2541-2547.

Research output: Contribution to journalArticle

Esposito, M, Vannozzi, M, Viale, M, Pellecchia, C, Civalleri, D & Gogioso, L 1995, 'Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum (II) in rats', Anticancer Research, vol. 15, no. 6 B, pp. 2541-2547.
Esposito, M. ; Vannozzi, M. ; Viale, M. ; Pellecchia, C. ; Civalleri, D. ; Gogioso, L. / Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum (II) in rats. In: Anticancer Research. 1995 ; Vol. 15, No. 6 B. pp. 2541-2547.
@article{bdad32b1e7d5467e9bc29ee850d8aff2,
title = "Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum (II) in rats",
abstract = "Para-aminobenzoic acid (PABA) has been previously repelled as being an inhibitor of DDP toxicity, and its use did not result in any observable loss in antitumor activity of DDP. The following studies investigated the effect of PABA on the pharmocokinetics and urinary excretion of cis-diammine-dichloroplatinum(II) (DDP) in male Sprague-Dawley rats. DDP was injected i.p. at the dose of 7.5 mg/kg in normal saline alone and with a concurrent i.p. injection of PABA (100 mg/kg). The combined treatment with PABA produced a significant increase in the plasma concentrations of total platinum, without affecting the levels of platinum species in the plasma ultrafiltrate. Similar results were also obtained in additional studies in rats receiving the same dose of DDP plus PABA through different routes of administration tie. DDP i.v. and PABA i.p.). Both the area under the total platinum plasma concentration-time curve (AUC) up to 60 min and AUC0-120 min were increased by PABA by an average of 113{\%} and 66{\%}, respectively. The administration of PABA in rats was followed by a substantial reduction in total urinary excretion of platinum (P <0.05) and by a significant (P <0.01) lower concentration of DDP derived platinum in the urine collected during the first 4 h after treatment. The renal clearance of filterable platinum was reduced by PABA by an average of 67.5{\%} from 1.11 to 0.36 ml/min/100 g body wt. Total 24-h urinary excretion of platinum was also decreased, although not significantly, by PABA. Urine volumes from rats treated with DDP + PABA were similar to those from animals receiving DDP alone. HPLC studies indicate that PABA reacts readily with the species generated from DDP in vitro, while the agent is essentially unreactive toward the parent DDP and does nor influence its decomposition rate. The overall data of this study suggest that the protective effect exerted by PABA on DDP toxicity may be at least partially due to its ability to interact with aquated DDP as well as to alter the renal excretion of platinum.",
keywords = "Acid, cis-diamminedichloroplatinum(II), Para-aminobenzoic, Pharmacokinetic interaction",
author = "M. Esposito and M. Vannozzi and M. Viale and C. Pellecchia and D. Civalleri and L. Gogioso",
year = "1995",
language = "English",
volume = "15",
pages = "2541--2547",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum (II) in rats

AU - Esposito, M.

AU - Vannozzi, M.

AU - Viale, M.

AU - Pellecchia, C.

AU - Civalleri, D.

AU - Gogioso, L.

PY - 1995

Y1 - 1995

N2 - Para-aminobenzoic acid (PABA) has been previously repelled as being an inhibitor of DDP toxicity, and its use did not result in any observable loss in antitumor activity of DDP. The following studies investigated the effect of PABA on the pharmocokinetics and urinary excretion of cis-diammine-dichloroplatinum(II) (DDP) in male Sprague-Dawley rats. DDP was injected i.p. at the dose of 7.5 mg/kg in normal saline alone and with a concurrent i.p. injection of PABA (100 mg/kg). The combined treatment with PABA produced a significant increase in the plasma concentrations of total platinum, without affecting the levels of platinum species in the plasma ultrafiltrate. Similar results were also obtained in additional studies in rats receiving the same dose of DDP plus PABA through different routes of administration tie. DDP i.v. and PABA i.p.). Both the area under the total platinum plasma concentration-time curve (AUC) up to 60 min and AUC0-120 min were increased by PABA by an average of 113% and 66%, respectively. The administration of PABA in rats was followed by a substantial reduction in total urinary excretion of platinum (P <0.05) and by a significant (P <0.01) lower concentration of DDP derived platinum in the urine collected during the first 4 h after treatment. The renal clearance of filterable platinum was reduced by PABA by an average of 67.5% from 1.11 to 0.36 ml/min/100 g body wt. Total 24-h urinary excretion of platinum was also decreased, although not significantly, by PABA. Urine volumes from rats treated with DDP + PABA were similar to those from animals receiving DDP alone. HPLC studies indicate that PABA reacts readily with the species generated from DDP in vitro, while the agent is essentially unreactive toward the parent DDP and does nor influence its decomposition rate. The overall data of this study suggest that the protective effect exerted by PABA on DDP toxicity may be at least partially due to its ability to interact with aquated DDP as well as to alter the renal excretion of platinum.

AB - Para-aminobenzoic acid (PABA) has been previously repelled as being an inhibitor of DDP toxicity, and its use did not result in any observable loss in antitumor activity of DDP. The following studies investigated the effect of PABA on the pharmocokinetics and urinary excretion of cis-diammine-dichloroplatinum(II) (DDP) in male Sprague-Dawley rats. DDP was injected i.p. at the dose of 7.5 mg/kg in normal saline alone and with a concurrent i.p. injection of PABA (100 mg/kg). The combined treatment with PABA produced a significant increase in the plasma concentrations of total platinum, without affecting the levels of platinum species in the plasma ultrafiltrate. Similar results were also obtained in additional studies in rats receiving the same dose of DDP plus PABA through different routes of administration tie. DDP i.v. and PABA i.p.). Both the area under the total platinum plasma concentration-time curve (AUC) up to 60 min and AUC0-120 min were increased by PABA by an average of 113% and 66%, respectively. The administration of PABA in rats was followed by a substantial reduction in total urinary excretion of platinum (P <0.05) and by a significant (P <0.01) lower concentration of DDP derived platinum in the urine collected during the first 4 h after treatment. The renal clearance of filterable platinum was reduced by PABA by an average of 67.5% from 1.11 to 0.36 ml/min/100 g body wt. Total 24-h urinary excretion of platinum was also decreased, although not significantly, by PABA. Urine volumes from rats treated with DDP + PABA were similar to those from animals receiving DDP alone. HPLC studies indicate that PABA reacts readily with the species generated from DDP in vitro, while the agent is essentially unreactive toward the parent DDP and does nor influence its decomposition rate. The overall data of this study suggest that the protective effect exerted by PABA on DDP toxicity may be at least partially due to its ability to interact with aquated DDP as well as to alter the renal excretion of platinum.

KW - Acid

KW - cis-diamminedichloroplatinum(II)

KW - Para-aminobenzoic

KW - Pharmacokinetic interaction

UR - http://www.scopus.com/inward/record.url?scp=0029549036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029549036&partnerID=8YFLogxK

M3 - Article

C2 - 8669820

AN - SCOPUS:0029549036

VL - 15

SP - 2541

EP - 2547

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -